www.bioscience.co.uk
Sales & Support: +44 (0)1223 316 855

*

Anti-IL-23α (Tildrakizumab), Humanized Antibody

Supplier:
Catalogue number:
A2159-100
Size:
100 µg
Product is available in:
  • UK
  • Ireland
  • Europe
  • USA
  • Rest of World
£581.00 Estimated delivery Wed 23 Jun
Shipping is calculated in checkout

The research-grade biosimilar is a humanised IgG1 monoclonal antibody that specifically targets the p19 subunit of IL-23 and thereby inhibits the interaction with the IL-23 receptor. IL-23 is a cytokine that plays an important role in mediating inflammatory and immune responses. Binding of the antibody to Il-23 blocks the release of pro-inflammatory cytokines and chemokines associated with psoriasis. The original drug received approval from the FDA in 2018 to treat patients with moderate-to-severe plaque psoriasis who are candidates for systemic and phototherapy

Product Type:

Antibodies

Species Reactivity:

Human

Storage Temp:

-80°C

Antibody Host:

Recombinant

Antibody Isotype:

IgG1, kappa

Formulation:

In PBS, pH 7.5

Antibody Type:

Monoclonal

UNSPSC Code:

12352203

Details Cat number & supplier Size Price
Anti-IL5 (Mepolizumab), Humanized Antibody A2158-100 · BioVision
A2158-100
BioVision
100 µg £581.00
100 µg
view
Anti-IGF-1R (Teprotumumab), Human IgG1 Antibody A2160-100 · BioVision
A2160-100
BioVision
100 µg £581.00
100 µg
view
Anti-BRCA1 Antibody A2157-100 · BioVision
A2157-100
BioVision
100 µl £435.00
100 µl
view
Anti-PD-1 (Toripalimab), Humanized Antibody A2161-100 · BioVision
A2161-100
BioVision
100 µg £581.00
100 µg
view
Anti-PD-1 (Sintilimab), Human IgG4 Antibody A2156-100 · BioVision
A2156-100
BioVision
100 µg £581.00
100 µg
view
Anti-IL-5Rα (Benralizumab), Humanized Antibody A2162-100 · BioVision
A2162-100
BioVision
100 µg £581.00
100 µg
view
Anti-IL-17Rα (Brodalumab), Human IgG2 Antibody A2155-100 · BioVision
A2155-100
BioVision
100 µg £581.00
100 µg
view